Holen Sie sich die Stockscreener-App
62.57
2.64%
1.61
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$60.96
Offen:
$60.81
24-Stunden-Volumen:
2.11M
Relative Volume:
0.92
Marktkapitalisierung:
$9.74B
Einnahmen:
$1.17B
Nettoeinkommen (Verlust:
$150.71M
KGV:
66.56
EPS:
0.94
Netto-Cashflow:
$245.03M
1W Leistung:
-5.06%
1M Leistung:
+12.48%
6M Leistung:
+24.27%
1J Leistung:
-15.16%
1-Tages-Spanne:
$60.48
$62.96
1-Wochen-Bereich:
$60.48
$65.86
52-Wochen-Spanne:
$46.01
$80.80
Bio Techne Corp Stock (TECH) Company Profile
Firmenname
Bio Techne Corp
Sektor
Branche
Telefon
(612) 379-8854
Adresse
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Vergleichen Sie TECH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TECH
Bio Techne Corp
|
62.57 | 9.49B | 1.17B | 150.71M | 245.03M | 0.94 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 398.11M | -1.03B | -868.57M | -5.7032 |
Bio Techne Corp Stock (TECH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-03 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-08-21 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-07-22 | Fortgesetzt | Stephens | Overweight |
| 2025-07-09 | Eingeleitet | TD Cowen | Buy |
| 2025-05-30 | Eingeleitet | Wells Fargo | Overweight |
| 2025-04-09 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-03-18 | Eingeleitet | Evercore ISI | Outperform |
| 2025-02-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-02-08 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-02-02 | Herabstufung | Stifel | Buy → Hold |
| 2023-12-07 | Eingeleitet | UBS | Buy |
| 2023-08-28 | Eingeleitet | William Blair | Outperform |
| 2023-01-10 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-04-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2021-09-15 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-08 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2021-02-23 | Hochstufung | Stifel | Hold → Buy |
| 2021-01-25 | Bestätigt | The Benchmark Company | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-07-15 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-05-27 | Herabstufung | Stifel | Buy → Hold |
| 2020-05-14 | Eingeleitet | The Benchmark Company | Buy |
| 2020-01-08 | Fortgesetzt | Stephens | Overweight |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-07-02 | Hochstufung | Janney | Neutral → Buy |
| 2019-01-14 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2018-10-31 | Herabstufung | Craig Hallum | Buy → Hold |
| 2018-10-17 | Eingeleitet | Goldman | Neutral |
| 2018-06-15 | Eingeleitet | Argus | Buy |
| 2017-07-13 | Eingeleitet | Wells Fargo | Market Perform |
| 2017-02-09 | Eingeleitet | Citigroup | Buy |
| 2017-01-18 | Eingeleitet | Deutsche Bank | Buy |
| 2016-11-10 | Fortgesetzt | Leerink Partners | Outperform |
| 2015-01-21 | Bestätigt | Robert W. Baird | Outperform |
| 2013-09-20 | Hochstufung | Robert W. Baird | Neutral → Outperform |
Alle ansehen
Bio Techne Corp Aktie (TECH) Neueste Nachrichten
Bio-Techne Corp. Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Asset Management One Co. Ltd. Has $264,000 Position in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp (TECH) Stock Forecasts - Yahoo Finance
Is Bio Techne Corporation stock a contrarian buyJuly 2025 Final Week & Growth-Oriented Investment Plans - newser.com
Why Bio Techne Corporation (TE1) stock could outperform next yearTrade Analysis Summary & Safe Swing Trade Setups - newser.com
Statistical indicators supporting Bio Techne Corporation’s strength2025 Risk Factors & Free Long-Term Investment Growth Plans - newser.com
Published on: 2025-10-31 01:10:28 - newser.com
How to forecast Bio Techne Corporation trends using time seriesQuarterly Profit Report & Daily Market Momentum Tracking - newser.com
Will Bio Techne Corporation (TE1) stock hit Wall Street targetsCEO Change & Verified Technical Signals - newser.com
Bio-Techne Corp (TECH) Stock forecasts - Yahoo! Finance UK
Bio-Techne Corporation (TECH) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Bio-Techne Corporation (TECH) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Bio-Techne Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Is Bio Techne Corporation (TE1) stock overpriced at current multiplesJuly 2025 Review & Weekly Breakout Watchlists - newser.com
Ownership Capital B.V. Cuts Stock Holdings in Bio-Techne Corp $TECH - MarketBeat
Why Bio Techne Corporation stock could benefit from AI revolution2025 Momentum Check & Risk Controlled Stock Pick Alerts - newser.com
Bio-Techne Corp $TECH Shares Purchased by Nisa Investment Advisors LLC - MarketBeat
Heatmap analysis for Bio Techne Corporation and competitorsCPI Data & Proven Capital Preservation Methods - newser.com
Is Bio Techne Corporation (TE1) stock positioned for secular growthTrade Entry Report & Risk Adjusted Swing Trade Ideas - newser.com
Can trapped investors hope for a rebound in Bio Techne Corporation2025 Market WrapUp & Free Risk Controlled Daily Trade Plans - newser.com
How analysts revise price targets for Bio Techne Corporation (TE1) stockJuly 2025 Short Interest & AI Powered Market Entry Strategies - newser.com
Bio-Techne (TECH) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Bio-Techne Corp. stock underperforms Wednesday when compared to competitors - MSN
How Investors Are Reacting To Bio-Techne (TECH) Unveiling Its ProximityScope Spatial Biology Assay - Yahoo Finance
Bio-techne launches new assay for protein interaction visualization - Investing.com
Will Bio Techne Corporation benefit from macro trendsMarket Volume Summary & Low Drawdown Momentum Trade Ideas - newser.com
Bio-Techne (NASDAQ: TECH) launches ProximityScope on BOND RX for protein interactions - Stock Titan
How to use Fibonacci retracement on Bio Techne CorporationWeekly Market Report & Growth Focused Stock Pick Reports - newser.com
Is Bio Techne Corporation (TE1) stock a top hedge fund pick2025 Short Interest & Community Consensus Picks - newser.com
Will Bio Techne Corporation price bounce be sustainable2025 Sector Review & Stock Portfolio Risk Control - newser.com
Bio-Techne Corp. stock underperforms Monday when compared to competitors - MarketWatch
4,462 Shares in Bio-Techne Corp $TECH Bought by Sage Mountain Advisors LLC - MarketBeat
First Citizens Bank & Trust Co. Sells 4,691 Shares of Bio-Techne Corp $TECH - MarketBeat
Can Bio Techne Corporation stock deliver consistent earnings growthJuly 2025 Volume & AI Optimized Trade Strategies - newser.com
Smart tools for monitoring Bio Techne Corporation’s price action2025 Institutional Moves & Weekly Watchlist for Hot Stocks - newser.com
What to expect from Bio Techne Corporation in the next 30 daysChart Signals & Community Trade Idea Sharing Platform - newser.com
What to do if you’re stuck in Bio Techne CorporationGap Down & Fast Entry and Exit Trade Plans - newser.com
Bio-Techne Corp $TECH Shares Bought by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Comparing Bio Techne Corporation in custom built stock radarsJuly 2025 Opening Moves & Fast Gaining Stock Reports - newser.com
Finanzdaten der Bio Techne Corp-Aktie (TECH)
Umsatz
Nettogewinn
Free Cashflow
ENV
Bio Techne Corp-Aktie (TECH) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Nusse Roeland | Director |
Aug 25 '25 |
Sale |
56.36 |
17,040 |
960,388 |
44,559 |
| BAUMGARTNER ROBERT V | Director |
Aug 25 '25 |
Option Exercise |
21.84 |
17,040 |
372,154 |
61,903 |
| BAUMGARTNER ROBERT V | Director |
Aug 25 '25 |
Sale |
56.21 |
17,040 |
957,818 |
44,863 |
1.62%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):